Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
47.15    -1.40 (-2.88%)
Bid:
46.70
Ask:
48.60
Spread: 1.90 (4.069%)
Market Cap: £187.71m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Director/PDMR Shareholding

28 Apr 2016 15:01

RNS Number : 7099W
CLS Holdings PLC
28 April 2016
 

 

 

 

 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

CLS Holdings plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

 

3. Full name of person(s) subject to thenotification obligation: iii

Creative Value Investment Group Limited ("CVIG")

4. Full name of shareholder(s) (if different from 3.):iv

Creative Value Investment I Limited

Creative Value Investment II Limited

Creative Value Investment III Limited

(together, the "CVIs")

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

28 April 2016

6. Date on which issuer notified:

28 April 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

Above 50%

      
 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

GB0001592475

Nil

Nil

Nil

 

21,369,429

 

50.70%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

21,369,429

50.70%

                 
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

The following undertakings, which immediately following the transaction were each directly held and beneficially owned by CVIG, directly hold the following number of shares in the issuer:

 

Creative Value Investment I Limited: 8,153,810 (19.34%)

Creative Value Investment II Limited: 6,094,828 (14.46%)

Creative Value Investment III Limited: 7,120,791 (16.89%)

 

Total: 50.70%

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will ceaseto hold:

 

12. Date on which proxy holder will cease to holdvoting rights:

 

 

13. Additional information:

Sten Mortstedt has transferred all of his shareholdings in the CVIs to CVIG in consideration for the issue of shares in CVIG to Sten Mortstedt. Immediately following that transaction, Sten Mortstedt settled his entire shareholding in CVIG into The Sten and Karin Mortstedt Family & Charity Trust. The beneficial interest of Sten Mortstedt in the issuer remains unchanged as a result of these transactions.

 

14. Contact name:

Peter Zonabend

15. Contact telephone number:

+41 81 252 55 47

   

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHAKFDKQBKDKQB
Date   Source Headline
11th Oct 20224:33 pmRNSDirector/PDMR Shareholding
6th Oct 20225:48 pmRNSDirector/PDMR Shareholding
5th Oct 20225:13 pmRNSDirector/PDMR Shareholding
4th Oct 20221:12 pmRNSDirector/PDMR Shareholding
29th Sep 202211:26 amRNSDirector/PDMR Shareholding
23rd Sep 20223:06 pmRNSDirector/PDMR Shareholding
22nd Sep 20223:41 pmRNSDirector/PDMR Shareholding
16th Sep 20224:56 pmRNSCompletion of Tender Offer and Total Voting Rights
15th Sep 20223:57 pmRNSDirector/PDMR Shareholding
12th Sep 20224:14 pmRNSResult of Tender Offer
9th Sep 202212:23 pmRNSResult of AGM
15th Aug 20224:27 pmRNSTender Offer
10th Aug 20224:19 pmRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSHalf-year Results
3rd Aug 20227:00 amRNSCLS announces the sale of three properties
2nd Aug 20225:38 pmRNSNotice of Results
14th Jul 202210:00 amRNSDirector/PDMR Shareholding
10th Jun 202210:31 amRNSCLS reclassified as REIT on EPRA index
9th Jun 20222:09 pmRNSDirector/PDMR Shareholding
12th May 20222:05 pmRNSDirector/PDMR Shareholding
12th May 20222:01 pmRNSDirector/PDMR Shareholding
11th May 20227:00 amRNSDividend Policy Update
28th Apr 20223:24 pmRNSAGM Statement
14th Apr 202211:20 amRNSDirector/PDMR Shareholding
28th Mar 20224:19 pmRNSAnnual Financial Report
18th Mar 202212:54 pmRNSDirector/PDMR Shareholding
18th Mar 202212:52 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSAnnual Financial Report
9th Mar 20225:42 pmRNSDirector/PDMR Shareholding
8th Mar 20227:00 amRNSAcquisition
17th Feb 20227:00 amRNSAcquisition
16th Feb 20227:00 amRNSAppointment of Joint Corporate Broker
10th Feb 20222:55 pmRNSHolding(s) in Company
9th Feb 20223:50 pmRNSDirector/PDMR Shareholding
9th Feb 202211:50 amRNSDirector/PDMR Shareholding
3rd Feb 202210:10 amRNSNotice of Results
26th Jan 202211:51 amRNSDirector/PDMR Shareholding
10th Jan 202211:43 amRNSDirector/PDMR Shareholding
29th Dec 20211:07 pmRNSConversion of UK operations to a REIT
21st Dec 20216:25 pmRNSPDMR Notification
16th Dec 20217:00 amRNSCLS secures five new leases in Germany
9th Dec 20217:00 amRNSDirector/PDMR Shareholding
2nd Dec 20219:52 amRNSDirector Declaration
11th Nov 202111:40 amRNSDirector/PDMR Shareholding
9th Nov 20219:24 amRNSDirector/PDMR Shareholding
3rd Nov 20217:00 amRNSTrading Update
13th Oct 20217:00 amRNSDirector/PDMR Shareholding
30th Sep 20217:00 amRNSCLS secures two new leases in Germany
20th Sep 20215:43 pmRNSDirector/PDMR Shareholding
10th Sep 20215:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.